ClinicalTrials.gov
ClinicalTrials.gov Menu

Docetaxel and Vinorelbine Plus Sargramostim in Metastatic Malignant Melanoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00256282
Recruitment Status : Completed
First Posted : November 21, 2005
Last Update Posted : March 20, 2013
Sponsor:
Collaborator:
Bayer
Information provided by (Responsible Party):
Chao Family Comprehensive Cancer Center, University of California, Irvine

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2012
  Actual Study Completion Date : July 2012

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 December 31, 2016 February 21, 2017
2 May 1, 2017  
3 January 12, 2018 February 6, 2018
4 February 22, 2018 March 19, 2018